Skip to main content
OpenTrials

Clinical trial condition

Extranodal NK/T-cell Lymphoma Nasal Type

Explore clinical trials studying Extranodal NK/T-cell Lymphoma Nasal Type. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Extranodal NK/T-cell Lymphoma Nasal Type trial results

Completed

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

NCT00901147

Conditions
Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Angioimmunoblastic T-cell Lymphoma, Enteropathy- Type T-cell Lymphoma, +20 more
Locations
  • Hospital Universiti Kebangsaan Malaysia ( HUKM ) Kuala Lumpur, Malaysia
  • Subang Jaya Medical Centre Subang Jaya, Selangor, Malaysia
  • National Cancer Center Singapore
  • Singapore General Hospital Singapore
View Trial Details

Related conditions